Clinical Trial Update: Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC) [Phase 2]

View source ↗

Summary

This clinical trial update reports the completed Phase 2 study evaluating photodynamic therapy for facial cutaneous squamous cell carcinoma in situ.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Cutaneous Squamous Cell Carcinoma in Situ

Drugs mentioned

• Photodynamic Therapy

Snippet

Sponsor: The Center for Clinical and Cosmetic Research | Conditions: Facial Cutaneous Squamous Cell Carcinoma in Situ | Phase 2 | Status: COMPLETED